Yanan Pi

587 total citations · 1 hit paper
13 papers, 357 citations indexed

About

Yanan Pi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yanan Pi has authored 13 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Yanan Pi's work include Ubiquitin and proteasome pathways (5 papers), Histone Deacetylase Inhibitors Research (3 papers) and RNA modifications and cancer (2 papers). Yanan Pi is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Histone Deacetylase Inhibitors Research (3 papers) and RNA modifications and cancer (2 papers). Yanan Pi collaborates with scholars based in China. Yanan Pi's co-authors include Bairong Xia, Kang Chen, Yu Gao, Leng Han, Weilin Jin, Ge Lou, Chang Yang, Tianbo Liu, Zhiqiang Wang and Shenghan Lou and has published in prestigious journals such as Cell Death and Differentiation, Frontiers in Immunology and Gene.

In The Last Decade

Yanan Pi

11 papers receiving 355 citations

Hit Papers

Bromodomain and extraterminal (BET) proteins: biological ... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanan Pi China 8 191 90 85 63 51 13 357
Mingqiu Hu China 12 190 1.0× 46 0.5× 46 0.5× 40 0.6× 36 0.7× 34 373
Xintong Xu China 11 128 0.7× 43 0.5× 33 0.4× 45 0.7× 62 1.2× 27 305
Ryosuke Tanino Japan 11 172 0.9× 54 0.6× 59 0.7× 118 1.9× 52 1.0× 25 379
Vittoria Raimondi Italy 9 248 1.3× 176 2.0× 34 0.4× 49 0.8× 42 0.8× 13 413
Xiaohan Lou China 11 186 1.0× 69 0.8× 55 0.6× 75 1.2× 92 1.8× 21 386
Li Tan China 13 259 1.4× 218 2.4× 38 0.4× 36 0.6× 43 0.8× 21 433
Zide Chen China 13 191 1.0× 90 1.0× 40 0.5× 36 0.6× 75 1.5× 20 382
Jorge Luis María Ruiz Brazil 11 175 0.9× 55 0.6× 35 0.4× 59 0.9× 48 0.9× 17 364
Jiao Chang China 13 245 1.3× 126 1.4× 33 0.4× 93 1.5× 63 1.2× 28 432
Yunxia Dong China 11 133 0.7× 57 0.6× 45 0.5× 26 0.4× 76 1.5× 12 366

Countries citing papers authored by Yanan Pi

Since Specialization
Citations

This map shows the geographic impact of Yanan Pi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanan Pi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanan Pi more than expected).

Fields of papers citing papers by Yanan Pi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanan Pi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanan Pi. The network helps show where Yanan Pi may publish in the future.

Co-authorship network of co-authors of Yanan Pi

This figure shows the co-authorship network connecting the top 25 collaborators of Yanan Pi. A scholar is included among the top collaborators of Yanan Pi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanan Pi. Yanan Pi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lou, Shenghan, Hao Wang, Gary Mo, et al.. (2025). A TRIM21–UCHL3–ITCH–SIPA1 axis promotes colorectal cancer growth and metastasis. Cancer Letters. 639. 218221–218221.
2.
Lou, Shenghan, Wei Huang, Jian Li, et al.. (2024). Clinical and prognostic significance of FBXL6 expression in ovarian cancer. Gene. 933. 148978–148978.
3.
Pi, Yanan, et al.. (2023). A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer. Medicina. 59(7). 1277–1277. 1 indexed citations
4.
Wang, Zhiqiang, Yuyang Wu, Yanan Pi, et al.. (2023). Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy. Signal Transduction and Targeted Therapy. 8(1). 420–420. 94 indexed citations breakdown →
5.
Pi, Yanan, et al.. (2023). Loss of SMURF2 expression enhances RACK1 stability and promotes ovarian cancer progression. Cell Death and Differentiation. 30(11). 2382–2392. 17 indexed citations
7.
Li, Xiaoyu, et al.. (2022). Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy. Frontiers in Oncology. 12. 894744–894744. 20 indexed citations
8.
Chen, Yu, Lin Hao, Yanan Pi, et al.. (2021). Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer. Frontiers in Oncology. 11. 616530–616530. 7 indexed citations
9.
Pi, Yanan, Bairong Xia, Mingzhu Jin, Weilin Jin, & Ge Lou. (2021). Exosomes: Powerful weapon for cancer nano-immunoengineering. Biochemical Pharmacology. 186. 114487–114487. 30 indexed citations
10.
Pi, Yanan, et al.. (2021). Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential. Frontiers in Immunology. 12. 697083–697083. 47 indexed citations
11.
Guo, Junnan, Bairong Xia, Chang Yang, et al.. (2021). Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential. Frontiers in Cell and Developmental Biology. 9. 680100–680100. 8 indexed citations
12.
Pi, Yanan, Junnan Guo, Ge Lou, & Binbin Cui. (2021). Comprehensive analysis of prognostic immune-related genes and drug sensitivity in cervical cancer. Cancer Cell International. 21(1). 639–639. 4 indexed citations
13.
Han, Leng, et al.. (2019). Anticancer activity of green synthesised gold nanoparticles from Marsdenia tenacissima inhibits A549 cell proliferation through the apoptotic pathway. Artificial Cells Nanomedicine and Biotechnology. 47(1). 4012–4019. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026